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Although five-year survival for paediatric medulloblastoma is now approaching 75%, there 
remains a large variability in individual patient outcome that can be difficult to predict at 
diagnosis. It is becoming increasingly important to develop methods of stratifying patients for 
improved disease management. Tumour temperature has been proposed as a novel marker of 
prognosis in other tumours and can be measured non-invasively by the technique of magnetic 
resonance spectroscopy (MRS) thermometry. MRS thermometry has previously detected 
differences between childhood brain tumour types. In this single centre study we investigated 
its potential to predict survival in medulloblastoma. Pre-treatment MRS thermometry data 
were acquired for 40 histology confirmed medulloblastoma patients, 18 of which had died by 
the end of the study. Treatment was according to national guidelines or clinical trials and 
included surgery, followed by chemotherapy and/or radiotherapy. Histopathology reports and 
standard radiological imaging were available for all cases.  Using Kaplan-Meier analysis with 
a median cut-off value, MRS thermometry identified patients with poor survival within the 
first 5 years (p<0.01). The mean apparent temperature in the poor prognosis group was 0.7°C 
higher than the good prognosis group, which may reflect increased metabolic rate in this 
group.  No correlations were found between MRS thermometry and Chang stage, histological 
subtype or radiological features, which individually were not predictors of survival. Age and 
sex did not significantly influence patient survival. All reported myc status for the cohort 
were negative. MRS thermometry can provide a novel non-invasive prognostic marker for 
medulloblastoma and potentially aid treatment stratification. 
